-
1
-
-
84868320535
-
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
-
Liang H, Cheung LW, Li J, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res 2012;22:2120-2129.
-
(2012)
Genome Res
, vol.22
, pp. 2120-2129
-
-
Liang, H.1
Cheung, L.W.2
Li, J.3
-
2
-
-
80155131218
-
ARIDIA, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers
-
Guan B, Wang TL, I Shih. ARIDIA, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2011;71:6718-6727.
-
(2011)
Cancer Res
, vol.71
, pp. 6718-6727
-
-
Guan, B.1
Wang, T.L.2
Shih, I.3
-
3
-
-
84866024623
-
Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
-
Xiao W, Awadallah A, Xin W. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. Int J Clin Exp Pathol 2012; 5:642-650.
-
(2012)
Int J Clin Exp Pathol
, vol.5
, pp. 642-650
-
-
Xiao, W.1
Awadallah, A.2
Xin, W.3
-
4
-
-
78650991499
-
Clinicopathological significance of loss of ARID1A Immunoreactivity in ovarian clear cell carcinoma
-
Maeda D, Mao TL, Fukayama M, et al. Clinicopathological significance of loss of ARID1A Immunoreactivity in ovarian clear cell carcinoma. Int J Mol Sci 2010;11:5120-5128.
-
(2010)
Int J Mol Sci
, vol.11
, pp. 5120-5128
-
-
Maeda, D.1
Mao, T.L.2
Fukayama, M.3
-
5
-
-
84871821809
-
Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms
-
Maeda D, Shih I. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013;20:45-52.
-
(2013)
Adv Anat Pathol
, vol.20
, pp. 45-52
-
-
Maeda, D.1
Shih, I.2
-
6
-
-
79953797962
-
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
-
Guan B, Mao TL, Panuganti PK, et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 2011;35:625-632.
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 625-632
-
-
Guan, B.1
Mao, T.L.2
Panuganti, P.K.3
-
7
-
-
79958238185
-
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
-
Wiegand KC, Lee AF, Al-Agha OM, et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 2011;224:328-333.
-
(2011)
J Pathol
, vol.224
, pp. 328-333
-
-
Wiegand, K.C.1
Lee, A.F.2
Al-Agha, O.M.3
-
8
-
-
84870674891
-
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
-
Rahman M, Nakayama K, Rahman MT, et al. Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer. Hum Pathol 2012;44:103-109.
-
(2012)
Hum Pathol
, vol.44
, pp. 103-109
-
-
Rahman, M.1
Nakayama, K.2
Rahman, M.T.3
-
10
-
-
79959653996
-
SWI/SNF nucleosome remodellers and cancer
-
Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011;11:481-492.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 481-492
-
-
Wilson, B.G.1
Roberts, C.W.2
-
11
-
-
84872868948
-
ARID1A mutations in cancer: Another epigenetic tumor suppressor?
-
Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 2013;3:35-43.
-
(2013)
Cancer Discov
, vol.3
, pp. 35-43
-
-
Wu, J.N.1
Roberts, C.W.2
-
12
-
-
82255183148
-
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
-
Wang K, Kan J, Yuen ST, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 2011;43:1219-1223.
-
(2011)
Nat Genet
, vol.43
, pp. 1219-1223
-
-
Wang, K.1
Kan, J.2
Yuen, S.T.3
-
13
-
-
78650878985
-
A proposed model for endometrial serous carcinogenesis
-
Zheng W, Xiang L, Fadare O, et al. A proposed model for endometrial serous carcinogenesis. Am J Surg Pathol 2011;35:e1-e14.
-
(2011)
Am J Surg Pathol
, vol.35
-
-
Zheng, W.1
Xiang, L.2
Fadare, O.3
-
14
-
-
84867403968
-
ARID1A expression loss in gastric cancer: Pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability
-
Abe H, Maeda D, Hino R, et al. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability. Virchows Arch 2012;461:367-377.
-
(2012)
Virchows Arch
, vol.461
, pp. 367-377
-
-
Abe, H.1
Maeda, D.2
Hino, R.3
-
15
-
-
84863746056
-
Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer
-
Wang DD, Chen YB, Pan K, et al. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PLoS One 2012;7:e40364.
-
(2012)
PLoS One
, vol.7
-
-
Wang, D.D.1
Chen, Y.B.2
Pan, K.3
-
16
-
-
84857467474
-
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
-
Jones S, Li M, Parsons DW, et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 2012;33:100-103.
-
(2012)
Hum Mutat
, vol.33
, pp. 100-103
-
-
Jones, S.1
Li, M.2
Parsons, D.W.3
-
17
-
-
77956356649
-
Methylation profiles of endometrioid and serous endometrial cancers
-
Seeber LM, Zweemer RP, Marchionni L, et al. Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 2010;17:663-673.
-
(2010)
Endocr Relat Cancer
, vol.17
, pp. 663-673
-
-
Seeber, L.M.1
Zweemer, R.P.2
Marchionni, L.3
-
18
-
-
84864413479
-
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation
-
Nout RA, Bosse T, Creutzberg CL, et al. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecol Oncol 2012;126:466-473.
-
(2012)
Gynecol Oncol
, vol.126
, pp. 466-473
-
-
Nout, R.A.1
Bosse, T.2
Creutzberg, C.L.3
-
19
-
-
0033645557
-
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients
-
de Leeuw WJ, Dierssen J, Vasen HF, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000;192:328-335.
-
(2000)
J Pathol
, vol.192
, pp. 328-335
-
-
De Leeuw, W.J.1
Dierssen, J.2
Vasen, H.F.3
-
20
-
-
12844266901
-
Identification of HNPCC by molecular analysis of colorectal and endometrial tumors
-
Lynch Syndrome (HNPCC) and Microsatellite Instability
-
Vasen HF, Hendriks Y, de Jong AE, et al. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers 2004;20:207-213. (Pubitemid 40164093)
-
(2004)
Disease Markers
, vol.20
, Issue.4-5
, pp. 207-213
-
-
Vasen, H.F.A.1
Hendriks, Y.2
De Jong, A.E.3
Van Puijenbroek, M.4
Tops, C.5
Brocker-Vriends, A.H.J.T.6
Wijnen, J.Th.7
Morreau, H.8
-
21
-
-
84876900933
-
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
-
Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013;0:1-13.
-
(2013)
Gut
, vol.0
, pp. 1-13
-
-
Vasen, H.F.1
Blanco, I.2
Aktan-Collan, K.3
-
22
-
-
79952381358
-
Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allelespecific qPCR
-
van ER, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allelespecific qPCR. PLoS One 2011;6:e17791.
-
(2011)
PLoS One
, vol.6
-
-
Van Er Licht, J.1
Schrumpf, M.2
-
23
-
-
77951844096
-
Early onset MSI-H colon cancer with MLH1 promoter methylation is there a genetic predisposition?
-
van Roon EH, van PM, Middeldorp A, et al. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer 2010;10:180.
-
(2010)
BMC Cancer
, vol.10
, pp. 180
-
-
Van Roon, E.H.1
Van Pm Middeldorp, A.2
-
24
-
-
0032534069
-
A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
-
Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257. (Pubitemid 28521189)
-
(1998)
Cancer Research
, vol.58
, Issue.22
, pp. 5248-5257
-
-
Boland, C.R.1
Thibodeau, S.N.2
Hamilton, S.R.3
Sidransky, D.4
Eshleman, J.R.5
Burt, R.W.6
Meltzer, S.J.7
Rodriguez-Bigas, M.A.8
Fodde, R.9
Ranzani, G.N.10
Srivastava, S.11
-
25
-
-
84875218081
-
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
-
Werner HM, Berg A, Wik E, et al. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol 2012;26:428-434.
-
(2012)
Mod Pathol
, vol.26
, pp. 428-434
-
-
Werner, H.M.1
Berg, A.2
Wik, E.3
-
26
-
-
77957946398
-
ARID1A mutations in endometriosis-associated ovarian carcinomas
-
Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010;363:1532-1543.
-
(2010)
N Engl J Med
, vol.363
, pp. 1532-1543
-
-
Wiegand, K.C.1
Shah, S.P.2
Al-Agha, O.M.3
-
27
-
-
77954950405
-
Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: A comparative analysis emphasizing the importance of distinguishing between these two groups
-
Bartosch C, Exposito MI, Lopes JM. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups. Int J Surg Pathol 2010;18:286-291.
-
(2010)
Int J Surg Pathol
, vol.18
, pp. 286-291
-
-
Bartosch, C.1
Exposito, M.I.2
Lopes, J.M.3
-
28
-
-
77951664346
-
Endometrial carcinoma: Controversies in histopathological assessment of grade and tumour cell type
-
Clarke BA, Gilks CB. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol 2010;63:410-415.
-
(2010)
J Clin Pathol
, vol.63
, pp. 410-415
-
-
Clarke, B.A.1
Gilks, C.B.2
-
29
-
-
47149101636
-
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
-
Medina PP, Sanchez-Cespedes M. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Epigenetics 2008;3:64-68.
-
(2008)
Epigenetics
, vol.3
, pp. 64-68
-
-
Medina, P.P.1
Sanchez-Cespedes, M.2
-
30
-
-
0037308717
-
Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: Correlation with poor prognosis
-
Reisman DN, Sciarrotta J, Wang W, et al. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 2003;63:560-566. (Pubitemid 36158131)
-
(2003)
Cancer Research
, vol.63
, Issue.3
, pp. 560-566
-
-
Reisman, D.N.1
Sciarrotta, J.2
Wang, W.3
Funkhouser, W.K.4
Weissman, B.E.5
-
31
-
-
0034326257
-
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines
-
Wong AK, Shanahan F, Chen Y, et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000;60:6171-6177.
-
(2000)
Cancer Res
, vol.60
, pp. 6171-6177
-
-
Wong, A.K.1
Shanahan, F.2
Chen, Y.3
-
32
-
-
84858155638
-
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas
-
Dal MM, Hong SM, Hebbar S, et al. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol 2012;43:585-591.
-
(2012)
Hum Pathol
, vol.43
, pp. 585-591
-
-
Dal, M.M.1
Hong, S.M.2
Hebbar, S.3
-
33
-
-
80053358456
-
INI1-deficient tumors: Diagnostic features and molecular genetics
-
Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011;35:e47-e63.
-
(2011)
Am J Surg Pathol
, vol.35
-
-
Hollmann, T.J.1
Hornick, J.L.2
-
34
-
-
44349105786
-
ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a
-
DOI 10.1073/pnas.0801802105
-
Gao X, Tate P, Hu P, et al. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc Natl Acad Sci USA 2008;105:6656-6661. (Pubitemid 351754562)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.18
, pp. 6656-6661
-
-
Gao, X.1
Tate, P.2
Hu, P.3
Tjian, R.4
Skarnes, W.C.5
Wang, Z.6
-
35
-
-
84859427109
-
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
-
Yamamoto S, Tsuda H, Takano M, et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol 2011;25:615-624.
-
(2011)
Mod Pathol
, vol.25
, pp. 615-624
-
-
Yamamoto, S.1
Tsuda, H.2
Takano, M.3
-
36
-
-
84860688574
-
Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance
-
Zhang X, Zhang Y, Yang Y, et al. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance. Cancer Epidemiol 2012;36:288-293.
-
(2012)
Cancer Epidemiol
, vol.36
, pp. 288-293
-
-
Zhang, X.1
Zhang, Y.2
Yang, Y.3
-
37
-
-
84055176558
-
Targeting the mTOR/4E-BP pathway in endometrial cancer
-
Korets SB, Czok S, Blank SV, et al. Targeting the mTOR/4E-BP pathway in endometrial cancer. Clin Cancer Res 2011;17:7518-7528.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7518-7528
-
-
Korets, S.B.1
Czok, S.2
Blank, S.V.3
-
38
-
-
84872653446
-
Promoter hypermethylation of ARID1A gene is responsible for its low mRNA rxpression in many invasive breast cancers
-
Zhang X, Sun Q, Shan M, et al. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA rxpression in many invasive breast cancers. PLoS One 2013;8:e53931.
-
(2013)
PLoS One
, vol.8
-
-
Zhang, X.1
Sun, Q.2
Shan, M.3
-
39
-
-
77957365492
-
DNA methylation in endometrial cancer
-
Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics 2010;5:491-498.
-
(2010)
Epigenetics
, vol.5
, pp. 491-498
-
-
Tao, M.H.1
Freudenheim, J.L.2
-
40
-
-
84861357097
-
Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors
-
McKenna ES, Tamayo P, Cho YJ, et al. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle 2012;11:1956-1965.
-
(2012)
Cell Cycle
, vol.11
, pp. 1956-1965
-
-
McKenna, E.S.1
Tamayo, P.2
Cho, Y.J.3
|